1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS AND EXCLUSIONS 32
1.3 MARKET SCOPE 32
1.3.1 MARKETS COVERED 32
FIGURE 1 DIGITAL PATHOLOGY INTEGRATION MARKET 32
1.3.2 YEARS CONSIDERED 33
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 2 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 35
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 36
FIGURE 3 PRIMARY SOURCES 36
2.1.2.1 Key data from primary sources 37
2.1.2.2 Insights from primary experts 38
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 38
2.1.2.3 Breakdown of primary sources 39
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, AND REGION 39
2.2 MARKET SIZE ESTIMATION 39
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 40
FIGURE 7 ILLUSTRATIVE EXAMPLE OF LEICA BIOSYSTEMS (SUBSIDIARY OF DANAHER CORPORATION) 40
FIGURE 8 SUPPLY-SIDE ANALYSIS: DIGITAL PATHOLOGY MARKET (2020) 41
FIGURE 9 BOTTOM-UP APPROACH 41
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 42
FIGURE 11 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE DIGITAL PATHOLOGY MARKET (2021–2026) 43
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 44
FIGURE 12 DATA TRIANGULATION METHODOLOGY 44
2.4 MARKET SHARE ESTIMATION 45
2.5 ASSUMPTIONS FOR THE STUDY 45
2.6 RISK ASSESSMENT 46
TABLE 1 RISK ASSESSMENT: DIGITAL PATHOLOGY MARKET 46
2.7 MARKET LIMITATIONS 46
2.7.1 METHODOLOGY-RELATED LIMITATIONS 46
2.7.2 SCOPE-RELATED LIMITATIONS 46
3 EXECUTIVE SUMMARY 47
FIGURE 13 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 47
FIGURE 14 DIGITAL PATHOLOGY MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 48
FIGURE 15 DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 48
FIGURE 16 DIGITAL PATHOLOGY MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 49
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET 50
4 PREMIUM INSIGHTS 51
4.1 DIGITAL PATHOLOGY MARKET OVERVIEW 51
FIGURE 18 THE RISING PREVALENCE OF CANCER IS A KEY FACTOR EXPECTED TO DRIVE THE GROWTH OF THE DIGITAL PATHOLOGY MARKET 51
4.2 NORTH AMERICA: DIGITAL PATHOLOGY SOLUTIONS MARKET, BY END USER & COUNTRY (2020) 52
FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN DIGITAL PATHOLOGY MARKET IN 2020 52
4.3 DIGITAL PATHOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 53
FIGURE 20 MARKET IN CHINA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 53
4.4 REGIONAL MIX: DIGITAL PATHOLOGY MARKET (2021–2026) 54
FIGURE 21 NORTH AMERICA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2021–2026) 54
4.5 DIGITAL PATHOLOGY MARKET: DEVELOPING VS. DEVELOPED MARKETS 54
FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 23 DIGITAL PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 55
5.2.1 DRIVERS 56
5.2.1.1 Increasing adoption of digital pathology to enhance lab efficiency 56
5.2.1.2 Rising incidence of cancer 56
TABLE 2 GLOBAL CANCER INCIDENCE, 2018 VS. 2025 57
5.2.1.3 Growing applications of digital pathology in drug development and companion diagnostics 57
5.2.2 RESTRAINTS 58
5.2.2.1 High cost of digital pathology systems 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 Introduction of affordable scanners for private pathology practices 58
5.2.3.2 Growing demand for personalized medicine 59
TABLE 3 US: GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES (2008–2020) 59
5.2.3.3 High growth opportunities in emerging economies 60
5.2.4 CHALLENGES 60
5.2.4.1 Shortage of drained pathologists 60
TABLE 4 NUMBER OF INHABITANTS PER PATHOLOGIST, BY COUNTRY, 2020 60
5.3 COVID-19 IMPACT ANALYSIS 61
5.3.1 IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET 61
FIGURE 24 IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET 61
5.4 ECOSYSTEM MARKET MAP 62
FIGURE 25 DIGITAL PATHOLOGY MARKET: ECOSYSTEM MARKET MAP 62
5.5 TRENDS IN AVERAGE SELLING PRICE 63
FIGURE 26 DIGITAL PATHOLOGY MARKET: AVERAGE REGIONAL PRICES OF DIGITAL PATHOLOGY SCANNERS 63
5.6 IMPACT OF THE NEW IVD REGULATION ON DIFFERENT MARKETS 63
FIGURE 27 TIMELINE AND TRANSITION TO NEW MDR AND IVDR 64
5.6.1 IMPACT ON CLINICAL LAB SERVICES 65
5.6.2 IMPACT ON IVD 65
5.6.3 IMPACT ON DIGITAL PATHOLOGY 65
5.7 TECHNOLOGY ANALYSIS 66
5.7.1 ARTIFICIAL INTELLIGENCE (AI) IN DIGITAL PATHOLOGY 66
5.8 PATENT ANALYSIS 67
5.8.1 METHODOLOGY 67
5.8.2 PUBLICATION TRENDS 67
FIGURE 28 PUBLICATION TRENDS, 2015–2021 67
5.8.3 JURISDICTION ANALYSIS 67
FIGURE 29 JURISDICTION ANALYSIS, 2015–2021 68
5.8.4 TOP APPLICANTS 68
FIGURE 30 TOP APPLICANTS, 2015–2021 68
6 DIGITAL PATHOLOGY MARKET, BY PRODUCT 69
6.1 INTRODUCTION 70
TABLE 5 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 70
6.2 SCANNERS 70
6.2.1 SCANNERS ACCOUNTED FOR THE LARGEST SHARE OF THE DIGITAL PATHOLOGY PRODUCTS MARKET IN 2020 70
TABLE 6 SCANNING MAGNIFICATION AND APPLICATIONS 71
TABLE 7 DIGITAL PATHOLOGY SCANNERS OFFERED BY KEY MARKET PLAYERS 71
TABLE 8 DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 73
TABLE 9 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION,
2019–2026 (USD MILLION) 73
TABLE 10 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2019–2026 (UNITS) 74
TABLE 11 DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 74
6.2.1.1 Brightfield scanners 74
TABLE 12 BRIGHTFIELD SCANNERS OFFERED BY KEY MARKET PLAYERS 74
TABLE 13 BRIGHTFIELD SCANNERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 75
6.2.1.2 Fluorescence scanners 76
TABLE 14 FLUORESCENCE SCANNERS OFFERED BY KEY MARKET PLAYERS 76
TABLE 15 FLUORESCENCE SCANNERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 76
6.2.1.3 Other scanners 77
TABLE 16 OTHER SCANNERS OFFERED BY KEY MARKET PLAYERS 77
TABLE 17 OTHER SCANNERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 77
6.3 SOFTWARE 78
6.3.1 DIGITAL PATHOLOGY SOFTWARE OFFERS ANALYTICAL AND HIGHLY ADVANCED FUNCTIONS 78
TABLE 18 DIGITAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS 78
TABLE 19 DIGITAL PATHOLOGY SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 79
TABLE 20 DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 79
6.3.1.1 Information management software 80
TABLE 21 INFORMATION MANAGEMENT SOFTWARE OFFERED BY KEY MARKET PLAYERS 80
TABLE 22 INFORMATION MANAGEMENT SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 80
6.3.1.2 Image analysis software 81
TABLE 23 IMAGE ANALYSIS SOFTWARE OFFERED BY KEY MARKET PLAYERS 81
TABLE 24 IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 81
6.3.1.3 Visualization software 82
TABLE 25 VISUALIZATION SOFTWARE OFFERED BY KEY MARKET PLAYERS 82
TABLE 26 VISUALIZATION SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 82
6.4 COMMUNICATION SYSTEMS 83
6.4.1 INTRODUCTION OF CLOUD-BASED COMMUNICATION SYSTEMS TO PROPEL THE GROWTH OF THIS MARKET 83
TABLE 27 COMMUNICATION SYSTEMS USED IN DIGITAL PATHOLOGY 83
TABLE 28 COMMUNICATION SYSTEMS OFFERED BY KEY MARKET PLAYERS 84
TABLE 29 COMMUNICATION SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 84
6.5 STORAGE SYSTEMS 85
6.5.1 REQUIREMENT FOR THE SAFE AND RELIABLE STORAGE OF HIGH-QUALITY IMAGES TO ENSURE MARKET GROWTH 85
TABLE 30 STORAGE SYSTEMS OFFERED BY KEY MARKET PLAYERS 85
TABLE 31 STORAGE SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 86
7 DIGITAL PATHOLOGY MARKET, BY TYPE 87
7.1 INTRODUCTION 88
TABLE 32 DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 88
7.2 HUMAN PATHOLOGY 88
7.2.1 THE COVID-19 PANDEMIC HAS LED TO AN INCREASING DEMAND FOR DIGITAL PATHOLOGY SOLUTIONS 88
TABLE 33 HUMAN DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 89
7.3 VETERINARY PATHOLOGY 89
7.3.1 VETERINARY DIGITAL PATHOLOGY REDUCES THE TURNAROUND TIME FOR ANIMAL DISEASE DIAGNOSIS─KEY FACTOR DRIVING THE MARKET GROWTH 89
TABLE 34 VETERINARY DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 90
8 DIGITAL PATHOLOGY MARKET, BY APPLICATION 91
8.1 INTRODUCTION 92
TABLE 35 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 92
8.2 DRUG DISCOVERY 92
8.2.1 INCREASING R&D SPENDING TO DRIVE THE GROWTH OF THIS SEGMENT 92
TABLE 36 APPLICATIONS OF DIGITAL PATHOLOGY IN DRUG DISCOVERY 92
TABLE 37 DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY,
2019–2026 (USD MILLION) 93
8.3 DISEASE DIAGNOSIS 94
8.3.1 USE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DIGITAL PATHOLOGY SOLUTIONS FOR DIAGNOSTIC PURPOSES TO DRIVE MARKET GROWTH 94
TABLE 38 DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION) 95
8.4 TELECONSULTATION 95
8.4.1 GROWING NEED FOR ACCURATE & FAST DIAGNOSIS TO DRIVE THE ADOPTION OF TELECONSULTATION FOR NUMEROUS CLINICAL APPLICATIONS 95
TABLE 39 DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY COUNTRY,
2019–2026 (USD MILLION) 96
8.5 TRAINING & EDUCATION 97
8.5.1 DIGITAL PATHOLOGY CAN IMPROVE EDUCATION & TRAINING PROVIDED TO PATHOLOGISTS IN ACADEMIC INSTITUTES 97
TABLE 40 DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY COUNTRY, 2019–2026 (USD MILLION) 97
9 DIGITAL PATHOLOGY MARKET, BY END USER 98
9.1 INTRODUCTION 99
TABLE 41 DIGITAL PATHOLOGY MARKET, BY END USER, 2019–2026 (USD MILLION) 99
TABLE 42 DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2019–2026 (USD MILLION) 99
TABLE 43 DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2019–2026 (UNITS) 100
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 100
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST & FASTEST-GROWING END USERS OF THE DIGITAL PATHOLOGY MARKET 100
TABLE 44 DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 101
TABLE 45 DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 101
TABLE 46 DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (UNITS) 102
9.3 HOSPITALS AND REFERENCE LABORATORIES 102
9.3.1 INCREASING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS TO DRIVE THE GROWTH OF THIS SEGMENT 102
TABLE 47 HOSPITAL DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS 103
TABLE 48 DIGITAL PATHOLOGY MARKET FOR HOSPITALS AND REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 104
TABLE 49 DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS AND REFERENCE LABORATORIES COMPANIES, BY REGION, 2019–2026 (USD MILLION) 104
TABLE 50 DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS AND REFERENCE LABORATORIES COMPANIES, BY REGION, 2019–2026 (UNITS) 105
9.4 ACADEMIC & RESEARCH INSTITUTES 105
9.4.1 FUNDING INVESTMENTS AND INITIATIVES TO BOOST THE GROWTH OF THIS END-USER SEGMENT IN THE DIGITAL PATHOLOGY MARKET 105
TABLE 51 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2019–2026 (USD MILLION) 106
TABLE 52 DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES COMPANIES, BY REGION, 2019–2026 (USD MILLION) 107
TABLE 53 DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES COMPANIES, BY REGION, 2019–2026 (UNITS) 107
10 DIGITAL PATHOLOGY MARKET, BY REGION 108
10.1 INTRODUCTION 109
TABLE 54 DIGITAL PATHOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION) 109
10.2 NORTH AMERICA 109
FIGURE 31 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT 110
TABLE 55 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 110
TABLE 56 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 111
TABLE 57 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 111
TABLE 58 NORTH AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 111
TABLE 59 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 112
TABLE 60 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 112
TABLE 61 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 112
TABLE 62 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019–2026 (USD MILLION) 113
TABLE 63 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019–2026 (UNITS) 113
10.2.1 US 113
10.2.1.1 Favorable reimbursement scenario for digital pathology in the
US to drive the adoption of digital pathology solutions 113
TABLE 64 US: CANCER INCIDENCE RATES, 2020 114
TABLE 65 US: DIGITAL PATHOLOGY CONFERENCES 115
TABLE 66 US: KEY MACROINDICATORS 115
TABLE 67 US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 115
TABLE 68 US: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 116
TABLE 69 US: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 116
TABLE 70 US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 116
TABLE 71 US: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 117
TABLE 72 US: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 117
10.2.2 CANADA 117
10.2.2.1 Cancer awareness initiatives by the government to drive the market growth in Canada 117
TABLE 73 CANADA: CANCER INCIDENCE RATES, 2020 118
TABLE 74 CANADA: DIGITAL PATHOLOGY INITIATIVES AND FUNDING 119
TABLE 75 CANADA: KEY MACROINDICATORS 119
TABLE 76 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 120
TABLE 77 CANADA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 78 CANADA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 79 CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 121
TABLE 80 CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 121
TABLE 81 CANADA: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 121
10.3 EUROPE 122
TABLE 82 EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 122
TABLE 83 EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 122
TABLE 84 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 123
TABLE 85 EUROPE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 123
TABLE 86 EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 123
TABLE 87 EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 124
TABLE 88 EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 124
TABLE 89 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2019–2026 (USD MILLION) 124
TABLE 90 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2019–2026 (UNITS) 125
10.3.1 UK 125
10.3.1.1 The UK is the largest market for digital pathology in Europe owing to rising government funding & initiatives 125
TABLE 91 CONFERENCES/COURSES HELD IN THE UK 126
TABLE 92 UK: KEY MACROINDICATORS 126
TABLE 93 UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 127
TABLE 94 UK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 95 UK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 96 UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 128
TABLE 97 UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 128
TABLE 98 UK: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 128
10.3.2 GERMANY 129
10.3.2.1 High healthcare expenditure and supportive health insurance in Germany to drive the adoption of digital pathology solutions 129
TABLE 99 GERMANY: CANCER INCIDENCE RATES, 2020 129
TABLE 100 GERMANY: KEY MACROINDICATORS 130
TABLE 101 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 130
TABLE 102 GERMANY: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 103 GERMANY: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 104 GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 105 GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 131
TABLE 106 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 132
10.3.3 SWEDEN 132
10.3.3.1 Increasing government initiatives for the deployment of digital pathology solutions to drive the market growth in Sweden 132
TABLE 107 SWEDEN: CANCER INCIDENCE RATES, 2020 132
TABLE 108 SWEDEN: KEY MACROINDICATORS 133
TABLE 109 SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026(USD MILLION) 133
TABLE 110 SWEDEN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 111 SWEDEN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 112 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 113 SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 135
TABLE 114 SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 135
10.3.4 DENMARK 136
10.3.4.1 High prevalence of cancer to support the market growth in Denmark 136
FIGURE 32 DENMARK: CANCER PREVALENCE, 2012–2020 136
TABLE 115 DENMARK: CANCER INCIDENCE RATES, 2020 136
TABLE 116 DENMARK: KEY MACROINDICATORS 137
TABLE 117 DENMARK: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 137
TABLE 118 DENMARK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 119 DENMARK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 120 DENMARK: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 121 DENMARK: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 139
TABLE 122 DENMARK: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 139
10.3.5 FRANCE 139
10.3.5.1 Increasing government funding and favorable insurance system among factors responsible for rising adoption of digital pathology solutions in France 139
TABLE 123 FRANCE: CANCER INCIDENCE RATES, 2020 140
TABLE 124 FRANCE: KEY MACROINDICATORS 140
TABLE 125 FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 141
TABLE 126 FRANCE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 127 FRANCE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 128 FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 129 FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 142
TABLE 130 FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 142
10.3.6 REST OF EUROPE (ROE) 143
TABLE 131 ROE: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 143
TABLE 132 ROE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 133 ROE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 134 ROE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 135 ROE: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 144
TABLE 136 ROE: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 145
10.4 ASIA PACIFIC (APAC) 145
TABLE 137 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 145
TABLE 138 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 146
TABLE 139 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 140 ASIA PACIFIC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 141 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 142 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 147
TABLE 143 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 147
TABLE 144 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019–2026 (USD MILLION) 148
TABLE 145 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019–2026 (UNITS) 148
10.4.1 CHINA 148
10.4.1.1 Favorable initiatives by the government for the adoption of telepathology in China 148
TABLE 146 CHINA: CANCER INCIDENCE RATES, 2020 149
TABLE 147 CHINA: KEY MACROINDICATORS 149
TABLE 148 CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 150
TABLE 149 CHINA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 150 CHINA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 151 CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 152 CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 151
TABLE 153 CHINA: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 151
10.4.2 JAPAN 152
10.4.2.1 Universal healthcare reimbursement for driving the adoption of digital pathology solutions in Japan 152
TABLE 154 JAPAN: CANCER INCIDENCE RATES, 2020 152
TABLE 155 JAPAN: KEY MACROINDICATORS 152
TABLE 156 JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 153
TABLE 157 JAPAN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 158 JAPAN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 159 JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 160 JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 154
TABLE 161 JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 154
10.4.3 INDIA 155
10.4.3.1 The growing number of cancer cases in India drive the market growth for digital pathology 155
TABLE 162 INDIA: CANCER INCIDENCE RATES, 2020 155
TABLE 163 INDIA: KEY MACROINDICATORS 156
TABLE 164 INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 156
TABLE 165 INDIA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 166 INDIA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 167 INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 168 INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 157
TABLE 169 INDIA: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 158
10.4.4 REST OF ASIA PACIFIC (ROAPAC) 158
TABLE 170 ROAPAC: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 159
TABLE 171 ROAPAC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 172 ROAPAC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 173 ROAPAC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 174 ROAPAC: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 160
TABLE 175 ROAPAC: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 160
10.5 LATIN AMERICA 161
TABLE 176 LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 161
TABLE 177 LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 161
TABLE 178 BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 162
TABLE 179 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 162
TABLE 180 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 162
TABLE 181 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 182 LATIN AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 183 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 184 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 164
TABLE 185 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 164
TABLE 186 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019–2026 (USD MILLION) 165
TABLE 187 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019–2026 (UNITS) 165
10.5.1 BRAZIL 165
10.5.1.1 Growing geriatric population and the subsequent increase in age-related disorders to drive the adoption of digital pathology solutions in Brazil 165
TABLE 188 BRAZIL: CANCER INCIDENCE RATES, 2020 166
TABLE 189 BRAZIL: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 166
TABLE 190 BRAZIL: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 191 BRAZIL: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 192 BRAZIL: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 193 BRAZIL: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 167
TABLE 194 BRAZIL: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 168
10.5.2 MEXICO 168
10.5.2.1 The increasing burden of infectious diseases to drive the uptake of digital pathology in Mexico 168
TABLE 195 MEXICO: CANCER INCIDENCE RATES, 2020 168
TABLE 196 MEXICO: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 169
TABLE 197 MEXICO: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
TABLE 198 MEXICO: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
TABLE 199 MEXICO: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 170
TABLE 200 MEXICO: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 170
TABLE 201 MEXICO: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 170
10.5.3 REST OF LATIN AMERICA (ROLATAM) 171
TABLE 202 ROLATAM: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 171
TABLE 203 ROLATAM: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 204 ROLATAM: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 172
TABLE 205 ROLATAM: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 172
TABLE 206 ROLATAM: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 172
TABLE 207 ROLATAM: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 INFRASTRUCTURAL DEVELOPMENTS IN THE REGION TO BOOST THE ADOPTION OF TECHNOLOGICALLY ADVANCED PATHOLOGY SOLUTIONS 173
TABLE 208 AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 174
TABLE 209 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 175
TABLE 210 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 211 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 212 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 213 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 176
TABLE 214 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 176
TABLE 215 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET,
BY END USER, 2019–2026 (USD MILLION) 177
TABLE 216 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET,
BY END USER, 2019–2026 (UNITS) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT-TO-WIN 178
FIGURE 33 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE DIGITAL PATHOLOGY MARKET 179
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 180
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN THE DIGITAL PATHOLOGY MARKET 180
11.4 COMPETITIVE BENCHMARKING 181
TABLE 217 FOOTPRINT OF COMPANIES IN THE DIGITAL PATHOLOGY MARKET 181
TABLE 218 PRODUCT: COMPANY FOOTPRINT (25 COMPANIES) 182
TABLE 219 END USER: COMPANY FOOTPRINT (25 COMPANIES) 183
TABLE 220 REGION: COMPANY FOOTPRINT (26 COMPANIES) 184
11.5 COMPETITIVE LEADERSHIP MAPPING 185
11.5.1 STAR 185
11.5.2 EMERGING LEADERS 185
11.5.3 PERVASIVE PLAYERS 185
11.5.4 PARTICIPANTS 186
FIGURE 35 DIGITAL PATHOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 186
11.6 COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES 187
11.6.1 PROGRESSIVE COMPANY 187
11.6.2 DYNAMIC COMPANY 187
11.6.3 STARTING BLOCK 187
11.6.4 RESPONSIVE COMPANY 187
FIGURE 36 DIGITAL PATHOLOGY MARKET: COMPETITIVE LEADERSHIP
MAPPING FOR OTHER COMPANIES (2020) 188
11.7 MARKET SHARE ANALYSIS 188
FIGURE 37 DIGITAL PATHOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 189
11.8 COMPETITIVE SCENARIO 190
11.8.1 PRODUCT LAUNCHES AND APPROVALS 190
TABLE 221 PRODUCT LAUNCHES AND APPROVALS, 2019–2021 190
11.8.2 DEALS 191
TABLE 222 DEALS, 2019–2021 191
12 COMPANY PROFILES 193
(Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 KEY PLAYERS 193
12.1.1 LEICA BIOSYSTEMS 193
TABLE 223 LEICA BIOSYSTEMS: BUSINESS OVERVIEW 193
FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 194
12.1.2 KONINKLIJKE PHILIPS N.V. 198
TABLE 224 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 198
FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 199
12.1.3 HAMAMATSU PHOTONICS 202
TABLE 225 HAMAMATSU PHOTONICS: BUSINESS OVERVIEW 202
FIGURE 40 HAMAMATSU PHOTONICS: COMPANY SNAPSHOT (2020) 203
12.1.4 F. HOFFMANN-LA ROCHE LTD. 205
TABLE 226 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW 205
FIGURE 41 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020) 206
12.1.5 SECTRA AB 209
TABLE 227 SECTRA AB: BUSINESS OVERVIEW 209
FIGURE 42 SECTRA AB: COMPANY SNAPSHOT (2020) 210
12.1.6 AKOYA BIOSCIENCES 213
TABLE 228 AKOYA BIOSCIENCES: BUSINESS OVERVIEW 213
FIGURE 43 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2020) 213
12.1.7 3DHISTECH 215
TABLE 229 3DHISTECH: BUSINESS OVERVIEW 215
12.1.8 APOLLO ENTERPRISE IMAGING CORP. 217
TABLE 230 APOLLO ENTERPRISE IMAGING CORP.: BUSINESS OVERVIEW 217
12.1.9 XIFIN, INC. 219
TABLE 231 XIFIN, INC.: BUSINESS OVERVIEW 219
12.1.10 HURON DIGITAL PATHOLOGY 220
TABLE 232 HURON DIGITAL PATHOLOGY: BUSINESS OVERVIEW 220
12.1.11 VISIOPHARM 222
TABLE 233 VISIOPHARM: BUSINESS OVERVIEW 222
12.1.12 CORISTA 224
TABLE 234 CORISTA: BUSINESS OVERVIEW 224
12.1.13 INDICA LABS 226
TABLE 235 INDICA LABS: BUSINESS OVERVIEW 226
12.1.14 OBJECTIVE PATHOLOGY SERVICES 228
TABLE 236 OBJECTIVE PATHOLOGY SERVICES: BUSINESS OVERVIEW 228
12.1.15 OPTRASCAN, INC. 229
TABLE 237 OPTRASCAN, INC.: BUSINESS OVERVIEW 229
12.1.16 GLENCOE SOFTWARE, INC. 231
TABLE 238 GLENCOE SOFTWARE, INC.: BUSINESS OVERVIEW 231
12.1.17 AIFORIA TECHNOLOGIES OY 232
TABLE 239 AIFORIA TECHNOLOGIES OY: BUSINESS OVERVIEW 232
TABLE 240 PAIGE: BUSINESS OVERVIEW 234
12.1.19 INSPIRATA, INC. 236
TABLE 241 INSPIRATA, INC.: BUSINESS OVERVIEW 236
12.1.20 PROSCIA, INC. 238
TABLE 242 PROSCIA, INC.: BUSINESS OVERVIEW 238
12.2 OTHER PLAYERS 241
12.2.1 PATHAI 241
12.2.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD. 241
12.2.3 MIKROSCAN TECHNOLOGIES, INC. 242
12.2.4 MOTIC DIGITAL PATHOLOGY 242
12.2.5 KANTERON SYSTEMS 242
*Details on Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 243
13.1 DISCUSSION GUIDE 243
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 247
13.3 AVAILABLE CUSTOMIZATIONS 249
13.4 RELATED REPORTS 249
13.5 AUTHOR DETAILS 250
1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS AND EXCLUSIONS 32
1.3 MARKET SCOPE 32
1.3.1 MARKETS COVERED 32
FIGURE 1 DIGITAL PATHOLOGY INTEGRATION MARKET 32
1.3.2 YEARS CONSIDERED 33
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 2 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 35
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 36
FIGURE 3 PRIMARY SOURCES 36
2.1.2.1 Key data from primary sources 37
2.1.2.2 Insights from primary experts 38
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 38
2.1.2.3 Breakdown of primary sources 39
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, AND REGION 39
2.2 MARKET SIZE ESTIMATION 39
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 40
FIGURE 7 ILLUSTRATIVE EXAMPLE OF LEICA BIOSYSTEMS (SUBSIDIARY OF DANAHER CORPORATION) 40
FIGURE 8 SUPPLY-SIDE ANALYSIS: DIGITAL PATHOLOGY MARKET (2020) 41
FIGURE 9 BOTTOM-UP APPROACH 41
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 42
FIGURE 11 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE DIGITAL PATHOLOGY MARKET (2021–2026) 43
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 44
FIGURE 12 DATA TRIANGULATION METHODOLOGY 44
2.4 MARKET SHARE ESTIMATION 45
2.5 ASSUMPTIONS FOR THE STUDY 45
2.6 RISK ASSESSMENT 46
TABLE 1 RISK ASSESSMENT: DIGITAL PATHOLOGY MARKET 46
2.7 MARKET LIMITATIONS 46
2.7.1 METHODOLOGY-RELATED LIMITATIONS 46
2.7.2 SCOPE-RELATED LIMITATIONS 46
3 EXECUTIVE SUMMARY 47
FIGURE 13 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 47
FIGURE 14 DIGITAL PATHOLOGY MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 48
FIGURE 15 DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 48
FIGURE 16 DIGITAL PATHOLOGY MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 49
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET 50
4 PREMIUM INSIGHTS 51
4.1 DIGITAL PATHOLOGY MARKET OVERVIEW 51
FIGURE 18 THE RISING PREVALENCE OF CANCER IS A KEY FACTOR EXPECTED TO DRIVE THE GROWTH OF THE DIGITAL PATHOLOGY MARKET 51
4.2 NORTH AMERICA: DIGITAL PATHOLOGY SOLUTIONS MARKET, BY END USER & COUNTRY (2020) 52
FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN DIGITAL PATHOLOGY MARKET IN 2020 52
4.3 DIGITAL PATHOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 53
FIGURE 20 MARKET IN CHINA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 53
4.4 REGIONAL MIX: DIGITAL PATHOLOGY MARKET (2021–2026) 54
FIGURE 21 NORTH AMERICA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2021–2026) 54
4.5 DIGITAL PATHOLOGY MARKET: DEVELOPING VS. DEVELOPED MARKETS 54
FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 23 DIGITAL PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 55
5.2.1 DRIVERS 56
5.2.1.1 Increasing adoption of digital pathology to enhance lab efficiency 56
5.2.1.2 Rising incidence of cancer 56
TABLE 2 GLOBAL CANCER INCIDENCE, 2018 VS. 2025 57
5.2.1.3 Growing applications of digital pathology in drug development and companion diagnostics 57
5.2.2 RESTRAINTS 58
5.2.2.1 High cost of digital pathology systems 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 Introduction of affordable scanners for private pathology practices 58
5.2.3.2 Growing demand for personalized medicine 59
TABLE 3 US: GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES (2008–2020) 59
5.2.3.3 High growth opportunities in emerging economies 60
5.2.4 CHALLENGES 60
5.2.4.1 Shortage of drained pathologists 60
TABLE 4 NUMBER OF INHABITANTS PER PATHOLOGIST, BY COUNTRY, 2020 60
5.3 COVID-19 IMPACT ANALYSIS 61
5.3.1 IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET 61
FIGURE 24 IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET 61
5.4 ECOSYSTEM MARKET MAP 62
FIGURE 25 DIGITAL PATHOLOGY MARKET: ECOSYSTEM MARKET MAP 62
5.5 TRENDS IN AVERAGE SELLING PRICE 63
FIGURE 26 DIGITAL PATHOLOGY MARKET: AVERAGE REGIONAL PRICES OF DIGITAL PATHOLOGY SCANNERS 63
5.6 IMPACT OF THE NEW IVD REGULATION ON DIFFERENT MARKETS 63
FIGURE 27 TIMELINE AND TRANSITION TO NEW MDR AND IVDR 64
5.6.1 IMPACT ON CLINICAL LAB SERVICES 65
5.6.2 IMPACT ON IVD 65
5.6.3 IMPACT ON DIGITAL PATHOLOGY 65
5.7 TECHNOLOGY ANALYSIS 66
5.7.1 ARTIFICIAL INTELLIGENCE (AI) IN DIGITAL PATHOLOGY 66
5.8 PATENT ANALYSIS 67
5.8.1 METHODOLOGY 67
5.8.2 PUBLICATION TRENDS 67
FIGURE 28 PUBLICATION TRENDS, 2015–2021 67
5.8.3 JURISDICTION ANALYSIS 67
FIGURE 29 JURISDICTION ANALYSIS, 2015–2021 68
5.8.4 TOP APPLICANTS 68
FIGURE 30 TOP APPLICANTS, 2015–2021 68
6 DIGITAL PATHOLOGY MARKET, BY PRODUCT 69
6.1 INTRODUCTION 70
TABLE 5 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 70
6.2 SCANNERS 70
6.2.1 SCANNERS ACCOUNTED FOR THE LARGEST SHARE OF THE DIGITAL PATHOLOGY PRODUCTS MARKET IN 2020 70
TABLE 6 SCANNING MAGNIFICATION AND APPLICATIONS 71
TABLE 7 DIGITAL PATHOLOGY SCANNERS OFFERED BY KEY MARKET PLAYERS 71
TABLE 8 DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 73
TABLE 9 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION,
2019–2026 (USD MILLION) 73
TABLE 10 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2019–2026 (UNITS) 74
TABLE 11 DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 74
6.2.1.1 Brightfield scanners 74
TABLE 12 BRIGHTFIELD SCANNERS OFFERED BY KEY MARKET PLAYERS 74
TABLE 13 BRIGHTFIELD SCANNERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 75
6.2.1.2 Fluorescence scanners 76
TABLE 14 FLUORESCENCE SCANNERS OFFERED BY KEY MARKET PLAYERS 76
TABLE 15 FLUORESCENCE SCANNERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 76
6.2.1.3 Other scanners 77
TABLE 16 OTHER SCANNERS OFFERED BY KEY MARKET PLAYERS 77
TABLE 17 OTHER SCANNERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 77
6.3 SOFTWARE 78
6.3.1 DIGITAL PATHOLOGY SOFTWARE OFFERS ANALYTICAL AND HIGHLY ADVANCED FUNCTIONS 78
TABLE 18 DIGITAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS 78
TABLE 19 DIGITAL PATHOLOGY SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 79
TABLE 20 DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 79
6.3.1.1 Information management software 80
TABLE 21 INFORMATION MANAGEMENT SOFTWARE OFFERED BY KEY MARKET PLAYERS 80
TABLE 22 INFORMATION MANAGEMENT SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 80
6.3.1.2 Image analysis software 81
TABLE 23 IMAGE ANALYSIS SOFTWARE OFFERED BY KEY MARKET PLAYERS 81
TABLE 24 IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 81
6.3.1.3 Visualization software 82
TABLE 25 VISUALIZATION SOFTWARE OFFERED BY KEY MARKET PLAYERS 82
TABLE 26 VISUALIZATION SOFTWARE MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 82
6.4 COMMUNICATION SYSTEMS 83
6.4.1 INTRODUCTION OF CLOUD-BASED COMMUNICATION SYSTEMS TO PROPEL THE GROWTH OF THIS MARKET 83
TABLE 27 COMMUNICATION SYSTEMS USED IN DIGITAL PATHOLOGY 83
TABLE 28 COMMUNICATION SYSTEMS OFFERED BY KEY MARKET PLAYERS 84
TABLE 29 COMMUNICATION SYSTEMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 84
6.5 STORAGE SYSTEMS 85
6.5.1 REQUIREMENT FOR THE SAFE AND RELIABLE STORAGE OF HIGH-QUALITY IMAGES TO ENSURE MARKET GROWTH 85
TABLE 30 STORAGE SYSTEMS OFFERED BY KEY MARKET PLAYERS 85
TABLE 31 STORAGE SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 86
7 DIGITAL PATHOLOGY MARKET, BY TYPE 87
7.1 INTRODUCTION 88
TABLE 32 DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 88
7.2 HUMAN PATHOLOGY 88
7.2.1 THE COVID-19 PANDEMIC HAS LED TO AN INCREASING DEMAND FOR DIGITAL PATHOLOGY SOLUTIONS 88
TABLE 33 HUMAN DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 89
7.3 VETERINARY PATHOLOGY 89
7.3.1 VETERINARY DIGITAL PATHOLOGY REDUCES THE TURNAROUND TIME FOR ANIMAL DISEASE DIAGNOSIS─KEY FACTOR DRIVING THE MARKET GROWTH 89
TABLE 34 VETERINARY DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 90
8 DIGITAL PATHOLOGY MARKET, BY APPLICATION 91
8.1 INTRODUCTION 92
TABLE 35 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 92
8.2 DRUG DISCOVERY 92
8.2.1 INCREASING R&D SPENDING TO DRIVE THE GROWTH OF THIS SEGMENT 92
TABLE 36 APPLICATIONS OF DIGITAL PATHOLOGY IN DRUG DISCOVERY 92
TABLE 37 DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY,
2019–2026 (USD MILLION) 93
8.3 DISEASE DIAGNOSIS 94
8.3.1 USE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DIGITAL PATHOLOGY SOLUTIONS FOR DIAGNOSTIC PURPOSES TO DRIVE MARKET GROWTH 94
TABLE 38 DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2019–2026 (USD MILLION) 95
8.4 TELECONSULTATION 95
8.4.1 GROWING NEED FOR ACCURATE & FAST DIAGNOSIS TO DRIVE THE ADOPTION OF TELECONSULTATION FOR NUMEROUS CLINICAL APPLICATIONS 95
TABLE 39 DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY COUNTRY,
2019–2026 (USD MILLION) 96
8.5 TRAINING & EDUCATION 97
8.5.1 DIGITAL PATHOLOGY CAN IMPROVE EDUCATION & TRAINING PROVIDED TO PATHOLOGISTS IN ACADEMIC INSTITUTES 97
TABLE 40 DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY COUNTRY, 2019–2026 (USD MILLION) 97
9 DIGITAL PATHOLOGY MARKET, BY END USER 98
9.1 INTRODUCTION 99
TABLE 41 DIGITAL PATHOLOGY MARKET, BY END USER, 2019–2026 (USD MILLION) 99
TABLE 42 DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2019–2026 (USD MILLION) 99
TABLE 43 DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2019–2026 (UNITS) 100
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 100
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST & FASTEST-GROWING END USERS OF THE DIGITAL PATHOLOGY MARKET 100
TABLE 44 DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 101
TABLE 45 DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 101
TABLE 46 DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (UNITS) 102
9.3 HOSPITALS AND REFERENCE LABORATORIES 102
9.3.1 INCREASING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS TO DRIVE THE GROWTH OF THIS SEGMENT 102
TABLE 47 HOSPITAL DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS 103
TABLE 48 DIGITAL PATHOLOGY MARKET FOR HOSPITALS AND REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION) 104
TABLE 49 DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS AND REFERENCE LABORATORIES COMPANIES, BY REGION, 2019–2026 (USD MILLION) 104
TABLE 50 DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS AND REFERENCE LABORATORIES COMPANIES, BY REGION, 2019–2026 (UNITS) 105
9.4 ACADEMIC & RESEARCH INSTITUTES 105
9.4.1 FUNDING INVESTMENTS AND INITIATIVES TO BOOST THE GROWTH OF THIS END-USER SEGMENT IN THE DIGITAL PATHOLOGY MARKET 105
TABLE 51 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2019–2026 (USD MILLION) 106
TABLE 52 DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES COMPANIES, BY REGION, 2019–2026 (USD MILLION) 107
TABLE 53 DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES COMPANIES, BY REGION, 2019–2026 (UNITS) 107
10 DIGITAL PATHOLOGY MARKET, BY REGION 108
10.1 INTRODUCTION 109
TABLE 54 DIGITAL PATHOLOGY MARKET, BY REGION, 2019–2026 (USD MILLION) 109
10.2 NORTH AMERICA 109
FIGURE 31 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT 110
TABLE 55 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 110
TABLE 56 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 111
TABLE 57 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 111
TABLE 58 NORTH AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 111
TABLE 59 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 112
TABLE 60 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 112
TABLE 61 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 112
TABLE 62 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019–2026 (USD MILLION) 113
TABLE 63 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019–2026 (UNITS) 113
10.2.1 US 113
10.2.1.1 Favorable reimbursement scenario for digital pathology in the
US to drive the adoption of digital pathology solutions 113
TABLE 64 US: CANCER INCIDENCE RATES, 2020 114
TABLE 65 US: DIGITAL PATHOLOGY CONFERENCES 115
TABLE 66 US: KEY MACROINDICATORS 115
TABLE 67 US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 115
TABLE 68 US: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 116
TABLE 69 US: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 116
TABLE 70 US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 116
TABLE 71 US: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 117
TABLE 72 US: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 117
10.2.2 CANADA 117
10.2.2.1 Cancer awareness initiatives by the government to drive the market growth in Canada 117
TABLE 73 CANADA: CANCER INCIDENCE RATES, 2020 118
TABLE 74 CANADA: DIGITAL PATHOLOGY INITIATIVES AND FUNDING 119
TABLE 75 CANADA: KEY MACROINDICATORS 119
TABLE 76 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 120
TABLE 77 CANADA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 78 CANADA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 79 CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 121
TABLE 80 CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 121
TABLE 81 CANADA: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 121
10.3 EUROPE 122
TABLE 82 EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 122
TABLE 83 EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 122
TABLE 84 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 123
TABLE 85 EUROPE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 123
TABLE 86 EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 123
TABLE 87 EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 124
TABLE 88 EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 124
TABLE 89 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2019–2026 (USD MILLION) 124
TABLE 90 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,
2019–2026 (UNITS) 125
10.3.1 UK 125
10.3.1.1 The UK is the largest market for digital pathology in Europe owing to rising government funding & initiatives 125
TABLE 91 CONFERENCES/COURSES HELD IN THE UK 126
TABLE 92 UK: KEY MACROINDICATORS 126
TABLE 93 UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 127
TABLE 94 UK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 95 UK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 96 UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 128
TABLE 97 UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 128
TABLE 98 UK: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 128
10.3.2 GERMANY 129
10.3.2.1 High healthcare expenditure and supportive health insurance in Germany to drive the adoption of digital pathology solutions 129
TABLE 99 GERMANY: CANCER INCIDENCE RATES, 2020 129
TABLE 100 GERMANY: KEY MACROINDICATORS 130
TABLE 101 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 130
TABLE 102 GERMANY: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 103 GERMANY: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 104 GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 105 GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 131
TABLE 106 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 132
10.3.3 SWEDEN 132
10.3.3.1 Increasing government initiatives for the deployment of digital pathology solutions to drive the market growth in Sweden 132
TABLE 107 SWEDEN: CANCER INCIDENCE RATES, 2020 132
TABLE 108 SWEDEN: KEY MACROINDICATORS 133
TABLE 109 SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026(USD MILLION) 133
TABLE 110 SWEDEN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 111 SWEDEN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 112 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 134
TABLE 113 SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 135
TABLE 114 SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 135
10.3.4 DENMARK 136
10.3.4.1 High prevalence of cancer to support the market growth in Denmark 136
FIGURE 32 DENMARK: CANCER PREVALENCE, 2012–2020 136
TABLE 115 DENMARK: CANCER INCIDENCE RATES, 2020 136
TABLE 116 DENMARK: KEY MACROINDICATORS 137
TABLE 117 DENMARK: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 137
TABLE 118 DENMARK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 119 DENMARK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 120 DENMARK: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 121 DENMARK: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 139
TABLE 122 DENMARK: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 139
10.3.5 FRANCE 139
10.3.5.1 Increasing government funding and favorable insurance system among factors responsible for rising adoption of digital pathology solutions in France 139
TABLE 123 FRANCE: CANCER INCIDENCE RATES, 2020 140
TABLE 124 FRANCE: KEY MACROINDICATORS 140
TABLE 125 FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 141
TABLE 126 FRANCE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 127 FRANCE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 128 FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 129 FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 142
TABLE 130 FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 142
10.3.6 REST OF EUROPE (ROE) 143
TABLE 131 ROE: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 143
TABLE 132 ROE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 133 ROE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 134 ROE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 135 ROE: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 144
TABLE 136 ROE: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 145
10.4 ASIA PACIFIC (APAC) 145
TABLE 137 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 145
TABLE 138 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 146
TABLE 139 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 140 ASIA PACIFIC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 141 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 142 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 147
TABLE 143 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 147
TABLE 144 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019–2026 (USD MILLION) 148
TABLE 145 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019–2026 (UNITS) 148
10.4.1 CHINA 148
10.4.1.1 Favorable initiatives by the government for the adoption of telepathology in China 148
TABLE 146 CHINA: CANCER INCIDENCE RATES, 2020 149
TABLE 147 CHINA: KEY MACROINDICATORS 149
TABLE 148 CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 150
TABLE 149 CHINA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 150 CHINA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 151 CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 152 CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 151
TABLE 153 CHINA: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 151
10.4.2 JAPAN 152
10.4.2.1 Universal healthcare reimbursement for driving the adoption of digital pathology solutions in Japan 152
TABLE 154 JAPAN: CANCER INCIDENCE RATES, 2020 152
TABLE 155 JAPAN: KEY MACROINDICATORS 152
TABLE 156 JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 153
TABLE 157 JAPAN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 158 JAPAN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 159 JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 160 JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 154
TABLE 161 JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 154
10.4.3 INDIA 155
10.4.3.1 The growing number of cancer cases in India drive the market growth for digital pathology 155
TABLE 162 INDIA: CANCER INCIDENCE RATES, 2020 155
TABLE 163 INDIA: KEY MACROINDICATORS 156
TABLE 164 INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 156
TABLE 165 INDIA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 166 INDIA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 167 INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 168 INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 157
TABLE 169 INDIA: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 158
10.4.4 REST OF ASIA PACIFIC (ROAPAC) 158
TABLE 170 ROAPAC: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 159
TABLE 171 ROAPAC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 172 ROAPAC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 173 ROAPAC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 174 ROAPAC: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 160
TABLE 175 ROAPAC: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 160
10.5 LATIN AMERICA 161
TABLE 176 LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 161
TABLE 177 LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 161
TABLE 178 BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 162
TABLE 179 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 162
TABLE 180 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 162
TABLE 181 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 182 LATIN AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 183 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 184 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 164
TABLE 185 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 164
TABLE 186 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019–2026 (USD MILLION) 165
TABLE 187 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2019–2026 (UNITS) 165
10.5.1 BRAZIL 165
10.5.1.1 Growing geriatric population and the subsequent increase in age-related disorders to drive the adoption of digital pathology solutions in Brazil 165
TABLE 188 BRAZIL: CANCER INCIDENCE RATES, 2020 166
TABLE 189 BRAZIL: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 166
TABLE 190 BRAZIL: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 191 BRAZIL: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 192 BRAZIL: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 193 BRAZIL: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 167
TABLE 194 BRAZIL: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 168
10.5.2 MEXICO 168
10.5.2.1 The increasing burden of infectious diseases to drive the uptake of digital pathology in Mexico 168
TABLE 195 MEXICO: CANCER INCIDENCE RATES, 2020 168
TABLE 196 MEXICO: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 169
TABLE 197 MEXICO: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
TABLE 198 MEXICO: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
TABLE 199 MEXICO: DIGITAL PATHOLOGY MARKET, BY TYPE, 2019–2026 (USD MILLION) 170
TABLE 200 MEXICO: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 170
TABLE 201 MEXICO: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 170
10.5.3 REST OF LATIN AMERICA (ROLATAM) 171
TABLE 202 ROLATAM: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 171
TABLE 203 ROLATAM: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 204 ROLATAM: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 172
TABLE 205 ROLATAM: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 172
TABLE 206 ROLATAM: DIGITAL PATHOLOGY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 172
TABLE 207 ROLATAM: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 INFRASTRUCTURAL DEVELOPMENTS IN THE REGION TO BOOST THE ADOPTION OF TECHNOLOGICALLY ADVANCED PATHOLOGY SOLUTIONS 173
TABLE 208 AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 174
TABLE 209 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 175
TABLE 210 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 211 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 212 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 213 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 176
TABLE 214 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER,
2019–2026 (USD MILLION) 176
TABLE 215 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET,
BY END USER, 2019–2026 (USD MILLION) 177
TABLE 216 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET,
BY END USER, 2019–2026 (UNITS) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT-TO-WIN 178
FIGURE 33 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE DIGITAL PATHOLOGY MARKET 179
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 180
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN THE DIGITAL PATHOLOGY MARKET 180
11.4 COMPETITIVE BENCHMARKING 181
TABLE 217 FOOTPRINT OF COMPANIES IN THE DIGITAL PATHOLOGY MARKET 181
TABLE 218 PRODUCT: COMPANY FOOTPRINT (25 COMPANIES) 182
TABLE 219 END USER: COMPANY FOOTPRINT (25 COMPANIES) 183
TABLE 220 REGION: COMPANY FOOTPRINT (26 COMPANIES) 184
11.5 COMPETITIVE LEADERSHIP MAPPING 185
11.5.1 STAR 185
11.5.2 EMERGING LEADERS 185
11.5.3 PERVASIVE PLAYERS 185
11.5.4 PARTICIPANTS 186
FIGURE 35 DIGITAL PATHOLOGY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 186
11.6 COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES 187
11.6.1 PROGRESSIVE COMPANY 187
11.6.2 DYNAMIC COMPANY 187
11.6.3 STARTING BLOCK 187
11.6.4 RESPONSIVE COMPANY 187
FIGURE 36 DIGITAL PATHOLOGY MARKET: COMPETITIVE LEADERSHIP
MAPPING FOR OTHER COMPANIES (2020) 188
11.7 MARKET SHARE ANALYSIS 188
FIGURE 37 DIGITAL PATHOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 189
11.8 COMPETITIVE SCENARIO 190
11.8.1 PRODUCT LAUNCHES AND APPROVALS 190
TABLE 221 PRODUCT LAUNCHES AND APPROVALS, 2019–2021 190
11.8.2 DEALS 191
TABLE 222 DEALS, 2019–2021 191
12 COMPANY PROFILES 193
(Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 KEY PLAYERS 193
12.1.1 LEICA BIOSYSTEMS 193
TABLE 223 LEICA BIOSYSTEMS: BUSINESS OVERVIEW 193
FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 194
12.1.2 KONINKLIJKE PHILIPS N.V. 198
TABLE 224 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 198
FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 199
12.1.3 HAMAMATSU PHOTONICS 202
TABLE 225 HAMAMATSU PHOTONICS: BUSINESS OVERVIEW 202
FIGURE 40 HAMAMATSU PHOTONICS: COMPANY SNAPSHOT (2020) 203
12.1.4 F. HOFFMANN-LA ROCHE LTD. 205
TABLE 226 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW 205
FIGURE 41 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020) 206
12.1.5 SECTRA AB 209
TABLE 227 SECTRA AB: BUSINESS OVERVIEW 209
FIGURE 42 SECTRA AB: COMPANY SNAPSHOT (2020) 210
12.1.6 AKOYA BIOSCIENCES 213
TABLE 228 AKOYA BIOSCIENCES: BUSINESS OVERVIEW 213
FIGURE 43 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2020) 213
12.1.7 3DHISTECH 215
TABLE 229 3DHISTECH: BUSINESS OVERVIEW 215
12.1.8 APOLLO ENTERPRISE IMAGING CORP. 217
TABLE 230 APOLLO ENTERPRISE IMAGING CORP.: BUSINESS OVERVIEW 217
12.1.9 XIFIN, INC. 219
TABLE 231 XIFIN, INC.: BUSINESS OVERVIEW 219
12.1.10 HURON DIGITAL PATHOLOGY 220
TABLE 232 HURON DIGITAL PATHOLOGY: BUSINESS OVERVIEW 220
12.1.11 VISIOPHARM 222
TABLE 233 VISIOPHARM: BUSINESS OVERVIEW 222
12.1.12 CORISTA 224
TABLE 234 CORISTA: BUSINESS OVERVIEW 224
12.1.13 INDICA LABS 226
TABLE 235 INDICA LABS: BUSINESS OVERVIEW 226
12.1.14 OBJECTIVE PATHOLOGY SERVICES 228
TABLE 236 OBJECTIVE PATHOLOGY SERVICES: BUSINESS OVERVIEW 228
12.1.15 OPTRASCAN, INC. 229
TABLE 237 OPTRASCAN, INC.: BUSINESS OVERVIEW 229
12.1.16 GLENCOE SOFTWARE, INC. 231
TABLE 238 GLENCOE SOFTWARE, INC.: BUSINESS OVERVIEW 231
12.1.17 AIFORIA TECHNOLOGIES OY 232
TABLE 239 AIFORIA TECHNOLOGIES OY: BUSINESS OVERVIEW 232
TABLE 240 PAIGE: BUSINESS OVERVIEW 234
12.1.19 INSPIRATA, INC. 236
TABLE 241 INSPIRATA, INC.: BUSINESS OVERVIEW 236
12.1.20 PROSCIA, INC. 238
TABLE 242 PROSCIA, INC.: BUSINESS OVERVIEW 238
12.2 OTHER PLAYERS 241
12.2.1 PATHAI 241
12.2.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD. 241
12.2.3 MIKROSCAN TECHNOLOGIES, INC. 242
12.2.4 MOTIC DIGITAL PATHOLOGY 242
12.2.5 KANTERON SYSTEMS 242
*Details on Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 243
13.1 DISCUSSION GUIDE 243
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 247
13.3 AVAILABLE CUSTOMIZATIONS 249
13.4 RELATED REPORTS 249
13.5 AUTHOR DETAILS 250
MarketsandMarkets